Insider · CIK 0001727809

Harsch Mutya

Reports to the SEC for 3 companies · STEWARTSVILLE, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001727809

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-23	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−22.5K sh	$0.90	−$20.2K	95,918
2026-06-30	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−3,464 sh	$0.65	−$2,254.025	118,434
2026-03-31	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−4,007 sh	$0.60	−$2,394.183	121,898
2025-12-31	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−3,579 sh	$0.58	−$2,076.178	125,905
2025-09-30	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−3,581 sh	$0.34	−$1,199.635	129,484
2025-06-30	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−3,581 sh	$1.65	−$5,908.65	133,065
2025-06-02	YARWYarrow Bioscience, Inc.A Award	CHIEF LEGAL OFFICER AND GC	AAward	+1,145 sh	$0.81	+$927.45	136,646
2025-03-31	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−8,828 sh	$1.58	−$13.9K	135,501
2025-01-21	YARWYarrow Bioscience, Inc. · Stock Option (right to buy)A Award	CHIEF LEGAL OFFICER AND GC	AAward	+230K sh	—	—	230,000
2024-12-31	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−4,697 sh	$3.35	−$15.7K	144,329
2024-09-30	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−105 sh	$1.88	−$197.4	149,026
2024-07-01	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−143 sh	$1.92	−$274.56	149,131
2024-04-01	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−161 sh	$3.08	−$495.88	149,274
2024-01-02	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−161 sh	$2.28	−$367.08	149,435
2024-01-01	YARWYarrow Bioscience, Inc. · Stock Option (right to buy)A Award	CHIEF LEGAL OFFICER AND GC	AAward	+62.5K sh	—	—	62,500
2024-01-01	YARWYarrow Bioscience, Inc.A Award	CHIEF LEGAL OFFICER AND GC	AAward	+62.5K sh	—	—	149,596
2023-12-13	YARWYarrow Bioscience, Inc. · Stock Option (right to buy)A Award	CHIEF LEGAL OFFICER AND GC	AAward	+62.5K sh	—	—	62,500
2023-12-13	YARWYarrow Bioscience, Inc.A Award	CHIEF LEGAL OFFICER AND GC	AAward	+62.5K sh	—	—	87,096
2023-10-02	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−1,154 sh	$3.83	−$4,419.82	24,596
2023-06-30	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−157 sh	$4.10	−$643.7	25,750
2023-06-08	Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−40K sh	—	—	0
2023-06-08	Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2023-05-31	YARWYarrow Bioscience, Inc.A Award	CHIEF LEGAL OFFICER AND GC	AAward	+3,664 sh	$3.46	+$12.7K	25,907
2023-03-31	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−478 sh	$3.08	−$1,472.24	22,243
2023-03-20	YARWYarrow Bioscience, Inc.P Purchase	CHIEF LEGAL OFFICER AND GC	PPurchase	+10K sh	$2.50	+$25K	22,721
2022-12-31	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−1,813 sh	$0.15	−$271.95	229,144
2022-09-30	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−1,813 sh	$0.22	−$404.299	230,957
2022-06-30	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−1,813 sh	$0.39	−$705.257	232,770
2022-06-03	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2022-03-31	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−3,630 sh	$0.65	−$2,359.5	234,583
2022-03-17	YARWYarrow Bioscience, Inc.A Award	CHIEF LEGAL OFFICER AND GC	AAward	+75K sh	—	—	238,213
2022-03-17	YARWYarrow Bioscience, Inc. · Stock OptionsA Award	CHIEF LEGAL OFFICER AND GC	AAward	+75K sh	—	—	75,000
2021-12-31	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−1,484 sh	$1.02	−$1,513.68	163,213
2021-10-11	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2021-09-30	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−1,484 sh	$1.39	−$2,062.76	164,697
2021-09-02	YARWYarrow Bioscience, Inc. · Stock OptionsA Award	CHIEF LEGAL OFFICER AND GC	AAward	+60.9K sh	—	—	60,860
2021-09-02	YARWYarrow Bioscience, Inc.A Award	CHIEF LEGAL OFFICER AND GC	AAward	+60.9K sh	—	—	166,181
2021-06-30	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−3,551 sh	$3.51	−$12.5K	105,322
2021-03-31	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−1,765 sh	$6.84	−$12.1K	108,873
2021-02-22	YARWYarrow Bioscience, Inc. · Stock OptionsA Award	CHIEF LEGAL OFFICER AND GC	AAward	+68.2K sh	—	—	68,162
2021-02-22	YARWYarrow Bioscience, Inc.A Award	CHIEF LEGAL OFFICER AND GC	AAward	+29.2K sh	—	—	110,638
2020-12-31	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−1,822 sh	$1.58	−$2,878.76	325,703
2020-11-30	YARWYarrow Bioscience, Inc.A Award	CHIEF LEGAL OFFICER AND GC	AAward	+10.5K sh	$1.45	+$15.1K	327,525
2020-09-30	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−1,822 sh	$1.66	−$3,024.52	317,065
2020-06-30	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−1,822 sh	$1.73	−$3,152.06	318,887
2020-05-06	YARWYarrow Bioscience, Inc. · Stock OptionsA Award	CHIEF LEGAL OFFICER AND GC	AAward	+150K sh	—	—	150,000
2020-05-06	YARWYarrow Bioscience, Inc.A Award	CHIEF LEGAL OFFICER AND GC	AAward	+150K sh	—	—	320,712
2020-04-06	YARWYarrow Bioscience, Inc.F Tax Payment	CHIEF LEGAL OFFICER AND GC	FTax Payment	−4,474 sh	$1.40	−$6,263.6	170,712
2020-04-03	YARWYarrow Bioscience, Inc.A Award	CHIEF LEGAL OFFICER AND GC	AAward	+92.3K sh	—	—	175,186
2020-04-03	YARWYarrow Bioscience, Inc.A Award	CHIEF LEGAL OFFICER AND GC	AAward	+26.4K sh	—	—	82,884

Recent filings

Accepted (ET)
Jul 244
Harsch Mutya0001727809-26-000008
SEC(opens sec.gov)
Jul 24
Harsch Mutya0001727809-26-000006
SEC(opens sec.gov)
Apr 24
Harsch Mutya0001727809-26-000004
SEC(opens sec.gov)
Jan 54
Harsch Mutya0001727809-26-000002
SEC(opens sec.gov)
Oct 24
Harsch Mutya0001727809-25-000003
SEC(opens sec.gov)
Jul 24
Harsch Mutya0001415889-25-019057
SEC(opens sec.gov)
Jun 34
Harsch Mutya0001415889-25-015383
SEC(opens sec.gov)
Apr 24
Harsch Mutya0001415889-25-009631
SEC(opens sec.gov)
Jan 234
Harsch Mutya0001415889-25-001924
SEC(opens sec.gov)
Jan 24
Harsch Mutya0001415889-25-000154
SEC(opens sec.gov)
Oct 24
Harsch Mutya0001415889-24-024381
SEC(opens sec.gov)
Jul 34
Harsch Mutya0001415889-24-019174
SEC(opens sec.gov)
Apr 34
Harsch Mutya0001415889-24-010067
SEC(opens sec.gov)
Jan 34
Harsch Mutya0001209191-24-000467
SEC(opens sec.gov)
Dec 154
Harsch Mutya0001209191-23-058817
SEC(opens sec.gov)
Oct 44
Harsch Mutya0001209191-23-051944
SEC(opens sec.gov)
Jul 54
Harsch Mutya0001209191-23-041107
SEC(opens sec.gov)

Companies

Address

C/O VYNE THERAPEUTICS INC. P.O. BOX 125

STEWARTSVILLE, NJ, 08886